AQP4 and myeloid sarcoma: This is generally consistent with previous observations of better visual recovery in younger patients with AQP4-abs-positive NMOSD-ON and MS-ON, although these studies did not control for the number of previous ON episodes, optic nerve signal transmission, and neuroaxonal retinal atrophy [21, 33, 34].